15 August 2019

5 Minutes With… Joško Bobanović from Sofinnova Partners

“In theory, the beauty about synthetic biology is that everything is possible. It allows us to design things without going through the classical disciplines like chemistry or physics.”

Sofinnova Partners is a well-known European venture capital firm. It invests in start-ups, early-stage companies, and corporate spin-offs. The companies…

Full text: https://biomarketinsights.com/5-minutes-with-josko-bobanovic-from-sofinnova-partners/


Share on Twitter+1Share on FacebookShare on XingShare on LinkedInShare via email